The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases

In vivo exploration of neurodegenerative diseases by positron emission tomography (PET) imaging has matured over the last 20 years, using dedicated radiopharmaceuticals targeting cellular metabolism, neurotransmission, neuroinflammation, or abnormal protein aggregates (beta-amyloid and intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupont, Anne-Claire, Largeau, Bérenger, Guilloteau, Denis, Santiago Ribeiro, Maria Joao, Arlicot, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985069/
https://www.ncbi.nlm.nih.gov/pubmed/29887768
http://dx.doi.org/10.1155/2018/7043578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985069/
https://www.ncbi.nlm.nih.gov/pubmed/29887768
http://dx.doi.org/10.1155/2018/7043578

Ejemplares similares